The effect of nifedipine on renal function in normotensive cyclosporin-a-treated renal allograft recipients

Nephrology Dialysis Transplantation

Volumn 5, Issue 11, 1990, Pages 962-968

  McNally, P G ^a   Walls, J ^a   Feehally, J ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cyclosporin nephrotoxicity; Nifedipine; Renal allograft recipients

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; NIFEDIPINE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; HUMAN; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; PRIORITY JOURNAL;

ADULT; CYCLOSPORINS; FEMALE; GLOMERULAR FILTRATION RATE; HEMODYNAMICS; HUMAN; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGE; NIFEDIPINE; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, HOMOLOGOUS;

EID: 0025615586     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/5.11.962     Document Type: Article

References (44)

1. Merion RM, White D.J.G., Thiru S, Evans DB, Caine RY. Cyclosporine: five years’ experience in cadaveric renal transplantation. N Engl J Med 1984; 310:148–154
2. Flechner SM, Van Buren C, Kerman RH, Kahen DB. The nephrotoxicity of cydosporine in renal transplant recipients. Transplant Proc 1983; 15 [Suppl 1]: 2689–2694
3. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclo- sporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699–705
4. Myers BD, Newton L, Boshkos C et al. Chronic injury of human renal microvessels with low-dose cydosporine therapy. Transplantation 1988; 46: 694–703
5. Murray BM, Paller MS, Ferris TF. Effect of cydosporine administration on renal hemodynamics in consdous rats. Kidney Int 1985; 28:767–774
6. Dieperink H, Leysacc PP, Starklint H, Jorgensen KA, Kemp E. Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethacin on cyclosporin A induced impairment of rat renal function. Eur J Clin Invest 1986; 16: 540–548
7. Curtis JJ, Luke RG, Dubovsky E, Diethelm AG, Whelchel JD, Jones P. Cydosporine in therapeutic doses increases renal allograft vascular resistance. Lancet 1986; 2:477–479
8. Siegl H, Ryffel B, Petrie R et al. Cydosporine, the renin-aldosterone system, and renal adverse reactions. Transplant Proc 1983; 15(4): 2719–2725
9. Benigni A, Perico N, Remuzzi G. Abnormalities of arachidonate metabolism in experimental dclosporin nephrotoxidty. Am J Nephrol 1989; 9[Suppl 1]: 72–77
10. Murray BM, Paller MS. Beneficial effect of renal denervation and prazosin on GFR and renal blood flow after cydosporine in rats. Clin Nephrol 1986; 25[Suppl 1]: S37–S39
11. Barros E.J.G., Boim MA, Ajzen H, Ramos OL, Schor N. Glomerular hemodynamics and hormonal partidpation on cydosporine nephrotoxicity. Kidney Int 1987; 32:19–25
12. Bunke M, Wilder L. Effect of verapamil on glomerular filtration rate and prostaglandin production during cydosporine administration. Transplantation 1988; 46:919–921
13. Van der Heide J.J.H., Bilo H.J.G., Tegzess AM, Donker A.J.M. The effects of dietary supplementation with fish oil on renal function in cyclosporine-treated renal transplant recipients. Transplantation 1990; 49: 523–527
14. Moran M, Mozes MF, Maddux MS et al. Prevention of acute graft rejection by the prostaglandin E, analogue misoprostol in renal- transplant recipients treated with cydosporine and prednisone. N Engl J Med 1990; 322: 1183–1188
15. Feehally J, Walls J, Mistry N et al. Does nifedipine ameliorate cyclosporin A nephrotoxicity? Br Med J 1987; 295: 310
16. Chantler C, Barratt TM. Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic add. Arch Dis Child 1972; 47:613–617
17. Wagoner RD, Newlon Tauxe W, Maher Ft, Hunt JC. Measurement of effective renal plasma flow with sodium iodohippurate I 131. JAMA 1964; 187:811–813
18. Gomez DM. Evaluation of renal resistances with special reference to changes in essential hypertension. J Clin Invest 1951; 30: 1143–1155
19. Liedtke RR, Duarte CG. Laboratory protocols and methods for the measurement of glomerular filtration rate and renal plasma flow. In Duarte CG, ed. Renal Function Tests. Clinical Laboratory Procedures and Diagnosis. Little, Brown, Boston 1980:49–63
20. Schmid BJ, Perry HE, Idle JR. Determination of nifedipine and its three principal metabolites in plasma and urine by automated electron-capture capillary gas chromatography. J Chromatogr 1988; 425(1): 107–119
21. English J, Evan A, Houghton DC, Bennett WM. Cyclosporine- induced acute renal dysfunction in the rat. Transplantation 1987; 44(1): 135–141
22. Rodriguez-Puyol D, Lamas S, Olivera A et al. Actions of cyclosporin A on cultured rat mesangial cells. Kidney Int 1989; 35: 632–637
23. Meyer-Lehnert H, Schrier RW. Cyclosporine A enhances vasopressin-induced Ca2* mobilisation and contraction in mesangial cells. Kidney Int 1988; 34: 89–97
24. Thomson SC, Tucker BJ, Gabbai F, Blantz RC. Functional effects on glomerular hemodynamics of short-term chronic cyclosporine in male rats. J Clin Invest 1989; 83: 960–969
25. Loutzenhiser R, Epstein M. Modification of the renal hemodynamic response to vasoconstrictors by calcium antagonists. Am J Nephrol 1987; 7[Suppl 1]: 7–16
26. Kreisberg JI, Venkatachalam M, Troyer D. Contractile properties of glomerular mesangial cells. Am J Physiol 1985; 249 (RenaI Fluid Electrolyte Physiol 18): F457–F463
27. Ausiello DA, Kreisberg JI, Roy C, Karnovsky MJ. Contraction of cultured rat glomerular mesangial cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin. J Clin Invest 1980; 65: 754–760
28. Meyer-Lehnert H, Schrier RW. Potential mechanism for cyclosporine A-induced vascular smooth muscle contraction. Hypertension 1989; 13:352–360
29. Pfeilschifter J, Ruegg UT. Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J 1987; 248: 883–887
30. Pfeilschifter J. Cyclosporin A augments vasoconstrictor-induced rise in intracellular free calcium in rat renal mesangial cells. Biochem Pharmacol 1988; 37:4205–4210
31. Baxter CR, Duggin GG, Willis N, Hall BM, Hornath JS, Tiller DJ. Cyclosporin A-induced increases in renin storage and release. Res Commun Chem Pathol Pharmacol 1982; 37: 305–312
32. Ichikawa I, Meile F, Brenner B. Reversal of renal cortical actions of angiotensin II by verapamil and manganese. Kidney Int 1979; 16: 137–147
33. Goldberg JP, Schrier RW. Effect of calcium membrane blockers on in vivo vasoconstrictor properties of norepinephrine, angiotensin II and vasopressin. Miner Electrolyte Metab 1984; 10:178–183
34. Stanek J, Kovarik J, Rasoul-Rockenschaub S, Silberbauer K. Renin-angiotensin-aldosterone system and vasopressin in cyclo- sporine-treated renal allograft recipients. Clin Nephrol 1987; 28: 186–189
35. Bantle JP, Nath KA, Sutherland D.E.R., Najarian JS, Ferris TF. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Arch Intern Med 1985 145: 505–508
36. Scharschmidt LR, Dunn MJ. Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin. J Clin lnvest 1983; 71:1756–1764
37. Kronbach T, Fischer V, Meyer UA. Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988; 43: 630–635
38. Lindholm A, Henricsson S. Verapamil inhibits cyclosporin metabolism. Lancet 1987; 1: 1262–1263
39. Cantarovich M, Lockiec F, Hiesse C, Charpentier B, Fries D. Confirmation of the interaction between cyclosporine and the calcium channel blocker nicardipine in renal transplant patients. Clin Nephrol 1987; 28(4): 190–193
40. Pochet JM, Pirson Y. Cyclosporin-diltiazem interaction. Lancet 1986; 1:979
41. Corea L, Miele N, Bentivoglio M, Boschetti E, Agabiti-Rosei E, Muiesan. Acute and chronic effects of nifedipine on plasma renin activity and plasma adrenaline and noradrenaline in controls and hypertensive patients. Clin Sci 1979; 57: 115S–117S
42. Slavin J, Taylor J. Cyclosporin, nifedipine and gingival hyperplasia. Lancet 1985; 2: 739
43. Cairns HS, Raval U, Neild GH. Failure of cyclosporine treated renal allograft recipients to increase glomerular filtration rate following an amino acid infusion. Transplantation 1988; 46:79–82
44. Tomlanovich S, Gollbetz H, Perlroth M, Stinson E, Myers BD. Limitations of creatinine in quantifying the severity of cyclosporine- induced chronic nephropathy. Am J Kidney Dis 1986; 8: 332–337